News
- Author:
- Mary Ann Moon
Publish date: March 20, 2017
Prophylactic augmentation of the abdominal wall using mesh at the ostomy site prevents the development of parastomal hernia, according to a report ...
Video
- Author:
- Mary Ann Moon
Publish date: March 19, 2017
WASHINGTON – In observational data only, so far, the prevalence and severity of subclinical leaflet thrombosis...
News
- Author:
- Mary Ann Moon
Publish date: March 16, 2017
The VA has removed barriers to treatment and allocated funds for the costly but effective drugs to treat HCV.
News
- Author:
- Mary Ann Moon
Publish date: March 14, 2017
Two screens to predict spontaneous preterm birth in low-risk women, which were rapidly adapted into clinical practice, proved to have little predic...
News
- Author:
- Mary Ann Moon
Publish date: March 14, 2017
More than four of five patients with atrial fibrillation who had an ischemic stroke were not taking adequate anticoagulation beforehand.
News
- Author:
- Mary Ann Moon
Publish date: March 14, 2017
People with cystic fibrosis survive an average of 10 years longer if they live in Canada than if they live in the United States, according to a rep...
News
- Author:
- Mary Ann Moon
Publish date: March 10, 2017
The findings reassure that RA patients who see lipids rise while on tocilizumab don’t have a higher risk of CV events.
News
- Author:
- Mary Ann Moon
Publish date: March 9, 2017
Reporting times for epidemiologic and laboratory data can be reduced to a few days.
News
- Author:
- Mary Ann Moon
Publish date: March 8, 2017
Researchers are now reporting the final follow-up results for the IRIS trial after a median of 10.9 years.
News
- Author:
- Mary Ann Moon
Publish date: March 1, 2017
Median overall survival for patients with ALL was significantly longer with blinatumomab than with chemotherapy.
News
- Author:
- Mary Ann Moon
Publish date: March 1, 2017
A phase II study provides evidence that a treatment targeting interleukin-31 may provide help to alleviate pruritus associated with atopic dermatit...
News
- Author:
- Mary Ann Moon
Publish date: February 28, 2017
The SIRROUND-T study indicates that the investigational interleukin-6 inhibitor sirukumab is safe and effective for patients with disease refractor...
News
- Author:
- Mary Ann Moon
Publish date: February 28, 2017
Recent changes in diet and exercise patterns may be to blame.
News
- Author:
- Mary Ann Moon
Publish date: February 28, 2017
Colorectal cancer has been a “good news” story over the past 10-15 years. In the United States we have seen 30% reduction in both incidence and mor...
News
- Author:
- Mary Ann Moon
Publish date: February 27, 2017
Children with systemic lupus erythematosus have high rates of serious infections requiring hospitalization, especially those with lupus nephritis.<...
